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Although the mechanism of receptor activation is rea-Liliana Attisano,‡ and Jeffrey L. Wrana*†
sonably well understood, there is little information about*Program in Developmental Biology
the potential downstream targets of the receptor com-Division of Gastroenterology
plex. Drosophila Mothers against dpp (MAD) (SekelskyThe Hospital for Sick Children
et al., 1995; Newfeld et al., 1996; Wiersdorff et al., 1996)Toronto, ON M5G 1X8
and the C. elegans sma-2, 3, and 4 genes (Savage etCanada
al., 1996) are among the first identified members of the†Department of Medical Genetics and Microbiology
MAD-related (MADR) family of proteins required for‡Department of Anatomy and Cell Biology
ser?thr kinase receptor signaling (reviewed in Mas-University of Toronto
sague´, 1996; Wrana and Attisano, 1996). AlthoughToronto, ON M5S 1A8
MADR proteins do not contain any known structuralCanada
motifs, they are highly conserved across species, and
all family members share highly conserved amino and
carboxy terminal regions termed the MH1 and MH2 do-Summary
mains, respectively (Wrana and Attisano, 1996). The im-
portance of MADR proteins in specifying biological re-MAD-related (MADR) proteins are essential intracellu-
sponses has been exemplified using Xenopus functionallar components of TGFb signaling pathways and are
assays. MADR1 appears to specify a ventral mesodermregulated by phosphorylation. Here, we demonstrate
phenotype similar to that obtained with BMP2, whereasthat MADR2 and not the related protein DPC4 tran-
MADR2 expression induces a dorsal phenotype typicallysiently interacts with the TGFb receptor and is directly
observed for activin/Vg/TGFb signaling (Baker and Har-phosphorylated by the complex on C-terminal serines.
land, 1996; Graff et al., 1996; Thomsen, 1996). SeveralInteraction of MADR2 with receptors and phosphory-
studies have suggested that MADR proteins might medi-lation requires activation of receptor I by receptor II
ate signaling through a nuclear function. MADR1 ap-and is mediated by the receptor I kinase. Mutation of
pears to redistribute from the cytoplasm to the nucleusthe phosphorylation sites generates a dominant nega-
upon induction of BMP signalingpathways, and in Xeno-tive MADR2 that blocks TGFb-dependent transcrip-
pus explant studies, mouse MADR2 is preferentially lo-tional responses, stably associates with receptors,
calized to the nucleus upon coinjection with activinand fails to accumulate in the nucleus in response to
(Baker and Harland, 1996; Hoodless et al., 1996; Liu etTGFb signaling. Thus, transient association and phos-
al., 1996). Further, fusion of MADR1 to a heterologousphorylation of MADR2 by the TGFb receptor is neces-
DNA binding domain allows it to act as a transcriptionalsary for nuclear accumulation and initiation of sig-
activator (Liu et al., 1996).naling.
Consistent with the observed biological responses,
MADR proteins are rapidly and specifically regulated byIntroduction
phosphorylation (Eppert et al., 1996; Hoodless et al.,
1996; Leichleider et al., 1996; Yingling et al., 1996).
The TGFb superfamily is a large multifunctional family
MADR1 becomes phosphorylated by the addition of
of ligands that are important for regulating cellular pro-
BMP2 and not TGFb or activin (Hoodless et al., 1996),
cesses throughout the growth and development of di- whereas MADR2 phosphorylation is induced by TGFb
verse organisms (Roberts and Sporn, 1990; Kingsley,
(Eppert et al., 1996). This phosphorylation event is im-
1994). TGFb-related factors elicit their biological effects
portant to MADR function since nonfunctional forms of
through a unique receptor system composed of hetero-
MADR2 identified in colorectal cancer arenot phosphor-
meric complexes of two related transmembrane ser?thr ylated (Eppert et al., 1996). Although MADR proteins
kinase receptors known as type I and II (reviewed in appear to be regulated by phosphorylation, neither the
Attisano et al., 1994; Miyazono et al., 1994; Massague´ kinase responsible for this modification nor the role of
and Weis-Garcia, 1996). Receptor activation occurs phosphorylation in MADR protein function is known.
upon binding of ligand to the type II receptor, which In this report, we demonstrate that MADR2, whose
then recruits and phosphorylates the type I receptor in phosphorylation is regulated by TGFb, transiently inter-
its glycine and serine-rich domain (GS domain). Once acts with the TGFb receptor complex in mammalian
phosphorylated, receptor I is activated and then propa- cells. We also show that MADR2 is directly phosphory-
gates the signal to downstream targets (Wrana et al., lated in vitro by the TGFb-activated receptor complex
1994; Attisano et al., 1996). Constitutively active type on the same sites as observed in vivo. Expression of
I receptors (Wieser et al., 1995; Attisano et al., 1996; MADR2 harboring a mutation of the identified phosphor-
Hoodless et al., 1996; Wiersdorff et al., 1996), which can ylation site leads to a stable association of mutant
signal biological responses in the absence of ligand and MADR2 with the receptor complex and a block of TGFb-
receptor II (Wieser et al., 1995), furthersupport themodel dependent signal transduction. Further, in contrast to
normal TGFb-induced nuclear accumulation of MADR2,
cellular localization of this mutant was unaltered. Thus,§These authors contributed equally to this work.
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Since transphosphorylation of receptor I by receptor
II is essential to initiate signaling, we investigated further
whether activation of TbRI by TbRII was required for
association of MADR2 with the receptor complex. To
test this, we cotransfected MADR2 together with various
wild-type and kinase-deficient versions of the type II
and I receptors and assessed the association of MADR2
with TGFb receptor complexes. While receptor com-
plexes containing wild-type TbRII and kinase-deficient
TbRI coprecipitated with MADR2, we detected no asso-
ciation between MADR2 and receptor complexes con-
taining kinase-defective type II receptors (Figure 1B).
Since this mutation specifically abolishes transphos-
phorylation of the type I receptor, these data indicate
that activation of TbRI by TbRII is required for the associ-
ation of MADR2 with the receptor complex. These find-
ings indicate that MADR2 transiently associates with
the TGFb receptor through its interaction with the typeFigure 1. MADR2 Transiently Interacts With the TGFb Receptor
I kinase.Complex
(A) Interaction of MADR2 with TGFb receptors. COS-1 cells tran-
siently transfected with empty vector (2) or Flag-MADR2, and the
indicated combinations of wild-type (WT) or kinase-deficient (KR) Phosphorylation of MADR2 In Vitro
TbRI and HA-tagged TbRII were affinity labeled with [125I]TGFb. Cell by the TGFb Receptor Complex
lysates were subjected to immunoprecipitation with anti-Flag M2 The transient nature of the interaction of MADR2 with
antibody and receptor complexes visualized by SDS-PAGE and au-
the TGFb receptors and the ability of the kinase-defec-toradiography (a-Flag IP). To confirm equivalent levels of receptor
tive type I receptor to stabilize this association stronglyexpression, aliquots of total cell lysates were analyzed by SDS-
suggest that MADR2 is a substrate for the type I recep-PAGE (bottom lanes, receptors).
(B) MADR2 interaction requires activated TbRI receptor. COS-1 cells tor. To directly test this, we asked whether bacterially
transfected with Flag-MADR2 and the indicated receptor constructs expressed MADR2 could function as a substrate for the
were processed as described in (A). Equivalent expression of Flag- purified TGFb receptor complex in an in vitro kinase
MADR2 protein was determined by immunoblotting total cell lysates
assay. TGFb receptors were isolated from Mv1Lu cellsusing anti-Flag M2 antibodies (bottom lane, a-Flag blot).
expressing endogenous receptors. To drive formation
and activation of receptor complexes, cells were treated
briefly with TGFb, and receptors were purified from cellMADR proteins mediate signaling by transmitting the
signal directly from the receptors to the nucleus. lysates using antibodies directed against TbRII. Immu-
noprecipitates were then subjected to an in vitro kinase
assay using bacterially expressed MADR2 as a sub-Results
strate. When receptors were isolated from Mv1Lu cells
in the absence of TGFb addition, only basal levels ofMADR2 Transiently Associates
with the TGFb Receptor MADR2 phosphorylation were observed (Figure 2A).
However, pretreatment of the cells with TGFb for 30To investigate possible associations between MADR
proteins and ser?thr kinase receptors, we focussed our min, which yields maximal heteromeric receptor com-
plex formation (Wrana et al., 1994), resulted ina dramaticefforts on MADR2, the phosphorylation of which we
recently showed is regulated by TGFb signaling path- increase in the phosphorylation of MADR2 by the recep-
tor complex. In contrast, when receptors were isolatedways (Eppert et al., 1996). Our initial attempts to detect
interactions using wild type TGFb receptors failed to from the mutant Mv1Lu derivative R1B cell line, which
expresses wild-type TbRII but lacks endogenous typedetect association of MADR2 with either TbRI or TbRII
receptor alone or with the receptor complex (Figure 1A, I receptor and are unresponsive to TGFb, no TGFb-
dependent increase in MADR2 phosphorylation couldand data not shown). However, given the mechanism of
TGFb receptor signaling, we reasoned that a physiologi- be detected. Phosphoamino acid analysis revealed that
while the basal phosphorylation occurred on serine andcal substrate of the complex might associate transiently
with TbRI and that to detect interaction may require the threonine residues, the TGFb-dependent increase oc-
curred predominantly on serine residues (Figure 2C).use of a catalytically inactive kinase to trap the sub-
strate. To investigate this possibility, we transiently ex- Thus, MADR2 is not a substrate of TbRII alone, and its
recognition and phosphorylation require ligand-inducedpressed FlagMADR2 together with wild-type TbRII and
either wild-type TbRI or its kinase-deficient version and assembly and activation of the heteromeric receptor
complex.visualized receptors by affinity-labeling with [125I]TGFb.
Analysis of MADR2 immunoprecipitates prepared from To determine whether the in vitro phosphorylation
mapped to the same sites on MADR2 as those phos-cells expressing wild-type receptors revealed that no
coprecipitating receptors were detected (Figure 1). In phorylated by activation of TGFb signaling in vivo, we
carried out tryptic phosphopeptide mapping. To studycontrast, in cells expressing wild-type TbRII and kinase-
deficient TbRI, receptor complexes could clearly be de- TGFb-inducedphosphorylation of MADR2 in intact cells,
we [32P]phosphate-labeled an Mv1Lu cell line that stablytected coprecipitating with MADR2 protein.
MADR Proteins: Substrates of ser–thr Kinase Receptors
1217
Figure 2. MADR2 Is a Substrate of the TGFb
Receptor Complex
(A) In vitro phosphorylation of GST-MADR2
by isolated receptor complexes. Nontrans-
fected Mv1Lu or R1B cells were incubated
with (1) or without (2) TGFb (0.5 nM) for 30
min at 378C. Receptor complexes were iso-
lated by immunoprecipitation using nonspe-
cific serum or anti-TbRII antibody (a-TbRII) as
indicated and then were incubated in kinase
assaybuffer containing[g-32P]ATP andbacte-
rially expressed MADR2 fusion protein (GST-
MADR2) as a substrate. Phosphorylation of
GST-MADR2 was visualized by SDS-PAGE
and autoradiography.
(B) In vivo phosphorylation of Flag-MADR2.
Mv1Lu cells stably transfected with Flag-
MADR2 were incubated with (1) or without
(2) TGFb (1 nM) for 15 min at 378C. Cells were
labeled 2 hr with [32P]phosphate, and Flag-
MADR2 was purified by immunoprecipitation
with anti-M2 Flag antibody.
(C) and (D) Phosphoamino acid analysis and
tryptic phosphopeptide mapping of in vivo
and in vitro labeled MADR2. The products
from partial acid hydrolysis of gel-purified
Flag-MADR2 (top panel) orGST-MADR2 (bot-
tom panel), from the indicated lanes in (A) and
(B) of Mv1Lu cells, were resolved by two-
dimensional electrophoresis in pH 1.9 and pH
3.5 buffers (C). Tryptic digests of the same
samples were resolved in two dimensions by
electrophoresis in pH 1.9 buffer and chroma-
tography in phosphochromatography buffer
(D). The relative migration of the phosphoser-
ine (pS), phosphothreonine (pT), and phos-
photyrosine (pY) standards are indicated (C).
The relevant phosphopeptides (arrows) and
the location of the sample application (1) are
marked (D). Mix, mixture of aliquots of in vivo
and in vitro labeled MADR2 from Mv1Lu cells
(1TGFb) from (A) and (B).
expresses low levels of FlagMADR2 (Eppert et al., 1996) that is incompletely phosphorylated in the in vitro reac-
tions (Boyle et al., 1991). To confirm that in vitro phos-and purified MADR2 from cell lysates using the Flag
M2 monoclonal antibody. The basal phosphorylation of phorylation was the same as that observed in vivo, a
mixture of tryptic fragments of MADR2 phosphorylatedMADR2 in these cell lines was low and mapped to a
single tryptic phosphopeptide (Figures 2B and 2D). under both conditions was analyzed. Mapping of this
sample demonstrated comigration of the phosphopep-However, brief treatment of the cells with TGFb resulted
in a rapid induction in MADR2 phosphorylation, which tides. These mapping data indicatethat phosphorylation
in vitro by purified receptors mimicks the phosphoryla-occurred predominantly on serine residues, on a single,
major phosphopeptide that migrated toward the anode tion observed in vivoand suggest that MADR2 is a direct
substrate of the heteromeric TGFb receptor complex in(Figure 2). Maps prepared from in vitro phosphorylated
MADR2 also showed nonspecific basal phosphorylation vivo.
To determine thespecificity of MADR interactionswithof the protein in assays using receptors isolated from
untreated cells. However, brief treatment of the cells the TGFb receptor, we analyzed the MAD-related pro-
tein, DPC4, which was first identified as a tumor-with TGFb prior to purification of the receptors led to the
appearance of a novel phosphopeptide that appeared to suppressor gene in pancreatic carcinoma (Hahn et al.,
1996). MADR immunoprecipitates were prepared fromcomigrate with the TGFb-dependent phosphopeptide
identified in vivo (Figure 2D). In the course of these [125I]TGFb affinity-labeled cells coexpressing TbRII and
kinase- deficient TbRI together with either MADR2 orexperiments, we consistently observed an additional
phosphopeptide in the in vitro maps that migrated on DPC4. While receptor complexes were detected in
MADR2 immunoprecipitates, no receptors coprecipitat-a diagonal with the peptide observed invivo (see Figures
2, 4, and 5). Since the migration of the TGFb-specific ing with DPC4 were observed (Figure 3A). Similarly, in
vitro kinase assays showed that TGFb receptors couldphosphopeptide toward the anode at pH 1.9 is consis-
tent with multiple phosphorylation on a single peptide, phosphorylate bacterially expressed MADR2 but not
DPC4 (Figure 3B). Thus, MADR2 and not another relatedthe additional peptide may represent a phosphoisomer
Cell
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Figure 3. MADR2 Association and Phosphorylation by the TGFb
Receptor Complex Is Specific
(A) Specificity of MADR2 association with the receptor complex.
COS-1 cells transfected with Flag-MADR2 or Flag-DPC4 together
Figure 4. The TGFb Receptor Phosphorylates MADR2 on thewith TbRII and either wild-type (WT) or kinase-deficient (KR) TbRI
C-Terminal Serine Residueswere affinity labeled with [125I]TGFb. Flag-MADR2 and Flag-DPC4
were immunoprecipitated with anti-Flag M2 antibody and associ- (A) Predicted phosphorylation site of MADR2. The amino acid se-
ated receptors visualized by SDS-PAGE and autoradiography quence of the carboxy terminus of MADR2 is shown. The predicted
(a-Flag IP). To confirm equal receptor expression, aliquots of total tryptic fragments generated from the wild-type (WT) and mutant
cell lysates were analyzed by SDS-PAGE (middle lane, receptors), R462A or R462H MADR2 are indicated (underline bracket). Under
and equivalent expression of Flag-MADR2 and Flag-DPC4 protein the conditions used for phosphopeptide mapping, multiple negative
was confirmed by immunoblotting total cell lysates using an anti- charges (2) are expected from the carboxy terminal fragment. The
M2 antibody (bottom lane, a-Flag blot). location of residues mutated in the MADR2 (3S-A) is boxed.
(B) Specificity of GST-MADR2 phosphorylation by the receptor com- (B) Phosphopeptide mapping of wild-type and mutant Flag-MADR2.
plex. COS-1 cells, transiently transfected with empty vector (2) or COS-1 cells, transfected with activated TbRI together with wild-
with TbRI and HA-tagged TbRII, were incubated with 0.5 nM TGFb type (WT) or mutant (R462A and R462H) Flag-MADR2, were labeled
for 30 min at 378C. Receptor complexes isolated from cell lysates with [32P]phosphate. Flag-MADR2 was isolated by immunoprecipita-
by immunoprecipitation using anti-HA antibodies were subjected to tion, and tryptic digests of gel-purified MADR2 were resolved in two
an in vitro kinase assay with GST-MADR2 or GST-DPC4 as a sub- dimensions as described in Figure 2. The relevant phosphopep-
strate. Phosphorylation of GST-MADR2 and GST-DPC4 was visual- tides (arrows) and the location of the sample application (1) are
ized by SDS-PAGE and autoradiography. The coomassie stained indicated.
gel indicating the relative level of MADR proteins is shown (bottom (C) Phosphopeptide mapping of wild type or a phosphorylation site
lane). mutant of MADR2. Mv1Lu cells were incubated with TGFb (0.5 nM)
for 30 min at 378C, and receptor complexes were isolated by immu-
noprecipitation with anti-TbRII antibody. Receptors were subjectedMADR specifically associates with and becomes phos-
to an in vitro kinase assay using wild-type GST-MADR2 (WT) or
phorylated by the TGFb receptors. mutant GST-MADR2(3S-A) as substrate. Phosphopeptide mapping
was described in (B).
MADR2 Is Phosphorylated on the C-Terminal (D) In vivo phosphorylation of wild-type and mutant Flag-MADR2.
COS-1 cells were transfected with empty vector (2) alone or combi-Serine Residues
nations of wild-type (WT) or activated (*) TbRI together with wild-To determine the relevance of phosphorylation to
type (WT) or mutant (3S-A) Flag-MADR2. Cells were labeled withMADR2 function, we determined the sites of phosphory-
[32P]phosphate, and Flag-MADR2 was purified by immunoprecipita-
lation by the TGFb receptor. The major phosphopeptide tion with anti-Flag M2 antibody and analyzed by SDS-PAGE and
derived from TGFb-dependent phosphorylation of autoradiography (32PO4). Equivalent expression of Flag-MADR2 pro-
MADR2 migrates rapidly toward the anode, suggesting tein was confirmed by immunoblotting (bottom lane, a-Flag blot).
that it is small with a net negative charge at pH 1.9. We
searched the sequence of MADR2 to identify putative
Coexpression of either of these MADR2s together withtryptic phosphopeptides that would possess this un-
the activated TGFb type I receptor resulted in increasedusual property and identified the C-terminal site as a
phosphorylation of the mutant protein that was indistin-likely candidate (Figure 4A). Under the oxidation condi-
guishable from wild-type MADR2 (data not shown).tions used, thecysteine residue together with phosphor-
However, tryptic phosphopeptide mapping of MADR2ylated serine residues at the tail would yield a peptide
(R462A) showed that the TGFb-dependent peptide mi-with a net negative charge.
grated more slowly toward the anode and had increasedTo confirm that this tryptic phosphopeptide was de-
mobility in the chromatographic step relative to the wildrived from the C-terminal tail of MADR2, we altered the
type (Figure 4B). The altered migration is consistent withtrypsin cleavage site by substituting the arginine at posi-
a reduction in the charge-to-mass ratio and an increasedtion 462 with alanine or histidine and examined TGFb-
dependent phosphorylation of the mutant proteins. hydrophobicity of the longer peptide generated from
MADR Proteins: Substrates of ser–thr Kinase Receptors
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Figure 5. Phosphorylation of MADR2 by the
TGFb Receptor Requires Activation of Re-
ceptor I by Receptor II
(A) Phosphorylation of GST-MADR2 in vitro
by wild-type and kinase-deficient receptor
complexes. COS-1 cells transiently trans-
fected with empty vector (2) or combinations
of wild-type (WT) and kinase-deficient (KR)
forms of TbRI and HA-tagged TbRII were in-
cubated with 1 nM TGFb for 15 min at 378C.
Receptor complexes were then isolated from
cell lysates by anti-HA immunoprecipitation
and subjected to an in vitro kinase assay us-
ing GST-MADR2 as a substrate. Phosphory-
lation was visualized by SDS-PAGE and auto-
radiography (in vitro kinase, top lane). The
coomassie stained gel indicating equal levels
of GST-MADR2 protein is shown (middle
lane). To confirm that similar amounts of re-
ceptor complexes were present in the kinase
assays, aliquots of transfected cells plated in
parallel were affinity labeled with [125I]TGFb
as in Figure 1, and receptors were immuno-
precipitated with anti-HA antibody (bottom
lane, receptors). The migration of TbRII and
TbRI is indicated.
(B) Tryptic phosphopeptide mapping of GST-MADR2. Tryptic digests of gel-purified GST-MADR2 from the indicated lanes were resolved in
two dimensions and visualized by autoradiography. The relevant phosphopeptides (arrows) and the location of the sample application (1)
are indicated.
tryptic cleavage of MADR2(R462A) (Figure 4A). Mapping Phosphorylation of MADR2 Requires
of MADR2(R462H) revealed that the TGFb-dependent Activation of TbRI by TbRII
phosphopeptide migrated even further to the cathode To determine the requirements for phosphorylation of
relative to R462A, consistent with introduction of an MADR2 by the TGFb receptor, we isolated receptor
additional positive charge into the peptide. These data complexes from cells transfected with various combina-
provide strongevidence that the major TGFb-dependent tions of wild-type or kinase-deficient receptors. For
phosphopeptide is derived from the C-terminus of these studies, we utilized COS-1 cells, which contain
MADR2. low levels of TGFb receptors and thus provide little en-
To confirm that the C-terminal serines were the sites dogenous background of wild-type receptors. As de-
of phosphorylation by the TGFb receptor, we generated scribed above, MADR2 was not phosphorylated by
MADR2(3S-A) in which the three C-terminal serine resi- TbRII alone but was strongly phosphorylated by immu-
dues were changed to alanine residues (Figure 4A). noprecipitates containing TbRII and TbRI (Figure 5A). In
Phosphopeptide mapping of bacterially expressed contrast, immunoprecipitates containing kinase-defi-
MADR2(3S-A) subjected to an in vitro kinase assay with cient TbRII and wild-type TbRI failed to phosphorylate
TGFb receptors showed that phosphorylation at the MADR2. Further, in cells cotransfected with kinase-defi-
TGFb-induced site was abolished (Figure 4C). Further, cient TbRI and wild-type TbRII, only slight increases in
the second peptide, consistently observed in the in vitro phosphorylation of MADR2 were observed (Figure 5A).
kinase assays, was also absent in maps of MADR2(3S-
This apparent increase could be due to either autophos-
A), providing support for the notion that this extra pep-
phorylated TbRII comigrating with glutathione S-trans-
tide represents a phosphoisomer and that multiple ser-
ferase (GST)-MADR2 or to a small amount of endoge-ines may be phosphorylated in the tail.
nous TbRI, which could coprecipitate with TbRII andWe also examined the phosphorylation of MADR2
phosphorylate MADR2. Phosphopeptide mapping fur-(3S-A) in intact cells. MADR2 or MADR2(3S-A) were
ther confirmed that specific phosphorylation of MADR2expressed alone or together with either wild type or
at the C-terminal serines only occurred when wild-typeconstitutively active TbRI, and cells were labeled with
TGFb receptors were used (Figure 5B). We also exam-[32P]phosphate. Previous studies have shown that sub-
ined whether MADR2 could function as a substrate ofstitution of a threonine at position 204 in TbRI yields a
unactivated TbRI. Using elevated levels of TbRI, we de-constitutivelyactive receptor that signals and phosphor-
tected some phosphorylation of MADR2 in the in vitroylates MADR proteins in the absence of ligand and type
kinase assays. However, this phosphorylation occurredII receptor (Wieser et al., 1995; Eppert et al., 1996). Con-
with low efficiency, was nonspecific, and did not occursistent with our in vitro observations, typical increases
on the TGFb-regulated site (data not shown). In thesein phosphorylation of wild-type MADR2 were observed
studies, using human TbRII, we consistently observedin cells expressing activated TbRI, while no increased
two additional phosphopeptides that were not presentphosphorylation of MADR2(3S-A) was detected (Figure
in analyses that utilized endogenous Mv1Lu receptors.4D). Together, these data show that the C-terminal ser-
We determined that these extra tryptic phosphopep-ine residues of MADR2 are the major sites of phosphory-
lation by the TGFb receptor. tides were derived from autophosphorylated human
Cell
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TbRII, which has an extra glycosylation site and comi-
grates with GST-MADR2 during SDS-PAGE (data not
shown).
These studies together with our analysis of receptor
association strongly suggest that MADR2 is a direct
substrate of the TGFb receptor complex, is phosphory-
lated by the receptor I kinase, and that this activity re-
quires transphosphorylation of receptor I by receptor II.
Since transphosphorylation within the TGFb receptor
complex is required for TGFb signaling, these results
suggest that MADR2 is a physiologically relevant sub-
strate of the TGFb receptor.
Phosphorylation of MADR2 by the TGFb
Receptor Is Required for Signaling
To gain more direct evidence that the interaction and
phosphorylation of MADR2 by the receptor is necessary
for the initiation of TGFb signaling, we investigated the
effects of MADR2(3S-A) expression on TGFb responses.
Figure 6. Phosphorylation of MADR2 by the TGFb Receptor Is Re-For these assays, we made use of p3TP-Lux, a TGFb-
quired for TGFb Signalingresponsive promoter that drives expression of a lucifer-
(A) Effect of wild-type and mutant MADR2 on TGFb-inducible genease reporter gene (Wrana et al., 1994) and the HepG2
expression. HepG2 cells were transfected with p3TP-Lux alone or
cell line, which expresses receptors and is responsive with wild-type (WT) and mutant (3S-A) Flag-MADR2 as indicated. In
to TGFb (Ca´rcamo et al., 1995). Cells were transfected some samples, 10-fold less MADR2(3S-A) DNA was used (0.1). Cells
with p3TP-Lux either alone or together with MADR2 or were incubated overnight in the absence (open bars) or presence
(closed bars) of 50 pM TGFb; the relative luciferase activity wasMADR2(3S-A), and luciferase activity was measured
measured in cell lysates.in cell lysates prepared from untreated cells or cells
(B) Interaction of wild-type and mutant Flag-MADR2 with the TGFbtreated with 50 pM TGFb for 16–20 hr. In control cells,
receptors. COS-1 cells were transiently transfected with the indi-
transfected with p3TP-Lux alone, TGFb induced a 10- cated expression constructs, affinity labeled with [125I]TGFb, and cell
fold increase in luciferase activity (Figure 6A). Cotrans- lysates were subjected to immunoprecipitation with anti-Flag M2
fection of MADR2 along with p3TP-Lux increased the antibody (a-Flag IP). To confirm equivalent levels of receptor expres-
sion, aliquots of total cell lysates were analyzed by SDS-PAGE (mid-sensitivity of the cells, yielding a 2-fold increase in re-
dle lane, receptors), and expression of Flag-MADR2 protein wassponsiveness of the promoter to TGFb. In contrast,
determined by immunoblotting of total cell lysates (bottom lane,when MADR2(3S-A) was used in these cotransfection
a-Flag blot).
assays, we observed a 6-fold decrease in TGFb-induced
luciferase activity. To determine whether wild-type
MADR2 could reverse this effect, we lowered the dose
by preventing association and phosphorylation of en-of MADR2(3S-A) to threshold levels where dominant
dogenous MADR2 protein by the receptors. Together,negative activity was still apparent (Figure 6A). Under
these results show that the transient association andthese conditions, coexpression of wild-type MADR2
phosphorylation of MADR2 by the TGFb receptors iswith MADR2(3S-A) restored TGFb-dependent induction
required for MADR2 function and initiation of TGFb sig-of the 3TP promoter back to control levels (Figure 6A).
naling.These data indicate that the phosphorylation site, mu-
tant MADR2(3S-A), acts as a dominant negative in TGFb
signaling by blocking the function of endogenous Phosphorylation of MADR2 Is Required
for Nuclear AccumulationMADR2 protein.
To determine the potential mechanism underlying the To investigate the potential role of phosphorylation in
MADR2 function, we investigated the subcellular local-dominant-negative activity of MADR2(3S-A), we investi-
gated the association of this mutant with the TGFb re- ization of MADR2 and MADR2(3S-A). We transiently
transfected HepG2 cells with wild-type or mutant Flag-ceptor. As described above, the interaction of wild-type
MADR2 was only detectable in the presence of kinase- MADR2 and visualized the proteins by immunofluores-
cence and confocal microscopy. Similar to our previousdeficient type I receptors (Figure 6B). In contrast, analy-
sis of the interaction of the MADR2(3S-A) with receptors observations on the distribution of MADR1, in control
cells, MADR2 immunoreactivity was diffuse and wasrevealed that the mutant protein stably associated with
wild-type TGFb receptors (Figure 6B). Furthermore, the found throughout the transfected cells (Figure 7). How-
ever, in transfectants expressing constitutively activelevel of interaction with the wild-type receptors was
comparable to that observed with complexes containing TbRI, Flag-MADR2 was found predominantly in the nu-
cleus, with little immunoreactivity detected in the cyto-kinase-deficient type I receptors. Since this mutation
abolishes TGFb receptor-dependent phosphorylation, plasm (Figure 7). Similar to wild-type MADR2, in control
transfectants, MADR2(3S-A) was found throughout thethese data indicate that MADR2 phosphorylation is re-
quired for dissociation of the protein from the receptor cell, indicating that the mutant protein does not have
an intrinsic defect in its ability to enter the nucleus.and suggest that MADR2(3S-A) blocks TGFb signaling
MADR Proteins: Substrates of ser–thr Kinase Receptors
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the upstream kinase responsible for MADR phosphory-
lation and the role that phosphorylation plays in regulat-
ing MADR2 function were unknown. In this report, we
demonstrate that MADR2 transiently associates with the
TGFb receptor complex and that this association re-
quires transphosphorylation of the type I receptor by
the type II receptor. We demonstrate that MADR2 is a
direct substrate of the TGFb receptor and that phos-
phorylation is catalyzed by the type I receptor kinase.
Phosphorylation of MADR2 by the receptor complex
occurs on the C-terminal serine residues, and this activ-
ity requires activation of receptor I byreceptor II. Expres-
sion of a phosphorylation site mutant of MADR2 func-
tions as a dominant negative in TGFb signaling and
stably associates with the wild-type TGFb receptors.
Furthermore, we show that phosphorylation of MADR2
is required for the nuclear accumulation of the protein
in response to TGFb signaling. Our results suggest a
model for the regulation and function of MADR2 in TGFb
signaling. Ligand-induced receptor complex formation
results in receptor II–mediated activation of receptor I,
Figure 7. Phosphorylation of MADR2 Is Required for TGFb-Depen-
which is then recognized by MADR2. MADR2 transientlydent Nuclear Accumulation
associates with the receptor, is phosphorylated by re-
HepG2 cells were transfected with wild-type or mutant (3S-A) Flag-
ceptor I kinase, and once phosphorylated, dissociatesMADR2 alone or together with activated TbRI (TbRI*). Flag-MADR2
and accumulates in the nucleus to carry out its effectorprotein was localized in the cells by immunoflorescence using anti-
Flag M2 antibody and a FITC-conjugated secondary antibody and functions. Thus, MADR proteins, as the physiological
analyzed by confocal microscopy. In the presence of the activated substrates of ser?thr kinase receptors, transmit signals
TbRI receptor, wild-type MADR2 displays prominant nuclear stain- directly from the receptor into the nucleus.
ing, whereas the phosphorylation site mutant (3S-A) displays a dif-
fuse staining pattern.
MADR2 Is a Substrate of the TGFb
Receptor Complex
However, in contrast to wild-type MADR2, in cells co- Biochemical and genetic studies of the molecular re-
transfected with activated TbRI, we could detect no quirements for signaling by ser?thr kinase receptors
change in the subcellular distribution of the mutant pro- have shown that signaling requires type II and I recep-
tein (Figure 7). To better quantitate these observations,
tors and is initiated when the type I receptor is trans-
we analyzed the localization of MADR2 by standard
phosphorylated by receptor II (Massague´ and Weis-Gar-
immunofluorescence microscopy using counterstain-
cia, 1996). A central role for the type I receptor in
ing with DAPI to identify nuclei. We examined 20 ran-
initiating the signal to downstream substrates is demon-dom fields (approximately 150–250 cells/sample) and
strated by the observation that constitutively active typecounted the percentage of cells displaying predomi-
I receptors signal in the absence of type II or ligandnantly nuclear staining. In control transfectantsexpress-
(Wieser et al., 1995). Numerous proteins that interacting either wild-type MADR2 or MADR2(3S-A) alone, only
with the TGFb receptor have been characterized, pri-7.5% and 9.1% of cells, respectively, displayed promi-
marily based on their interaction with TGFb receptornent nuclear staining. However, coexpression of wild-
kinase domains in yeast two hybrid screens. However,type MADR2 with activated TbRI resulted in an almost
some of these, such as TRIP1 or farnesyl-transferase-a10-fold increase (70.5%) in cells displaying nuclear lo-
are constitutively phosphorylated by unactivated recep-calization of the protein. In contrast, when MADR2(3S-
tor kinases or are not substrates, as in the case ofA) was coexpressed with activated TbRI, no significant
FKBP12 (Wang et al., 1994; Chen et al., 1995; Kawabatachange in subcellular localization was detected, and
et al., 1995; Ventura et al., 1996; Wang et al., 1996a,only 6.5% of cells had predominant nuclear staining.
1996b). Thus, these receptor-interacting molecules areThese data indicate that phosphorylation of MADR2 by
not likely to be directly involved in initiating signalingtheTGFb receptors is required for the nuclear accumula-
but may serve an accessory orregulatory role in receptortion of MADR2 and TGFb signaling.
function. In contrast to these previous studies, our stud-
ies on MADR2 show that the interaction and phosphory-
lation of the protein by the TGFb receptor is transient,Discussion
occurs via the type I receptor kinase, and requires acti-
vation of receptor I by receptor II. These observationsRecent studies have demonstrated that MAD-related
are consistent with the model of ser?thr kinase receptorproteins, which are components of the ser–thr kinase
activation and support the notion that MADR2 is a physi-receptor signaling pathways, are regulated by phos-
ologically relevant downstream target of the TGFb re-phorylation (Eppert et al., 1996; Hoodless et al., 1996;
Leichleider et al., 1996; Yingling et al., 1996). However, ceptor.
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Receptor Association with MADR2 Requires with wild-type receptors. Moreover, this mutation func-
tions as a dominant negative, blocking TGFb signaling.Activation of Receptor I
Association of MADR2 with the TGFb receptor requires Thus, the phosphorylation of MADR2 and its transient
association with the receptor is essential for MADR2the activation of receptor I by receptor II, indicating that
MADR2 does not interact directly with receptor I in the function in TGFb signal transduction. Previous studies
of MADR1 and MADR2 suggest that MADR proteinsabsence of ligand. Since activation of receptor I occurs
via phosphorylation in the GS domain, these observa- may function in ser?thr kinase receptor signaling by
transmitting signals into the nucleus (Baker and Harland,tions suggest that this event is important for MADR2
interaction with the receptor. One potential mechanism 1996; Hoodless et al., 1996; Liu et al., 1996). Therefore,
the transient interaction of MADR2 with the receptorconsistent with our data is a model in which phosphory-
lation of the GS domain results in MADR2 recognition may be essential in allowing the phosphorylated protein
to enter the nucleus and is consistent with a nuclearof receptor I. The phosphorylated GS domain may serve
as a docking site for MADR2 protein or may bind an function for MADR proteins. Based on the observation
that MAD-3 can synergize with DPC4 to induce TGFb-accessory molecule that serves as a site for MADR2
interaction. Alternatively, phosphorylation in the GS do- like responses, Zhang et al. (1996) proposed that this
MADR protein may act in TGFb signaling. Consistentmain may function to alter the conformation of the kinase
domain, thus allowing binding and phosphorylation of with this, these authors reported that MAD-3, like
MADR2, associates with the TGFb receptor. However,MADR2 by the active site of the kinase.
in contrast to our studies, TGFb-dependent regulation
of MAD-3 phosphorylation was not demonstrated. Com-
Receptors Phosphorylate MADR2 parison of MADR2 and MAD-3 sequences reveals that
on the C-Terminal Serines these proteins share 91% identity, suggesting that they
Our studies to map the phosphorylation site on MADR2 may have similar functions, and further studies will be
have led to the identification of the C-terminal serines required to clarify this issue.
as the site for phosphorylation by the TGFb receptors.
The presence of phosphoisomers in the peptide maps
MADR2 Phosphorylation Regulatesof MADR2phosphorylated in vitro suggests that multiple
its Nuclear Accumulationserines are phosphorylated in the tail. We have at-
Investigations inboth mammalian and Xenopus systemstempted to identify which of these serines are targeted
have shown that activation of ser–thr kinase receptorby the receptor kinase. However, mutation of individual
signaling pathways results in the nuclear accumulationserine residues appears to block TGFb-dependent in-
of MADR proteins (Baker and Harland, 1996; Hoodless etcreases in MADR2 phosphorylation in intact cells (data
al., 1996; Liu et al., 1996). Our analysis of the subcellularnot shown). Further, we have been unable to obtain thus
distribution of MADR2 shows that this protein is distrib-far sufficient quantities of the TGFb-dependent phos-
uted throughout the cell in unstimulated cultures butphopeptide from in vitro assays for microsequence anal-
redistributes into the nucleus in response to TGFb sig-ysis. Thus, unambiguous determination of which of the
naling. In contrast, the phosphorylation site mutantthree serines are phosphorylated has not beenobtained,
MADR2(3S-A) fails to accumulate in the nucleus. Thus,and we continue topursue this important question. Inter-
phosphorylation of MADR2 by the receptor is requiredestingly, the C-terminal serine residues are conserved
for its nuclear accumulation in response to TGFb sig-in MADR1, and preliminary experiments indicate that
naling.these sites area target for BMP2-dependent phosphory-
There are numerous examples of signaling systemslation (M. M. S.and J. L. W., unpublished data). Recently,
in which activation of cytoplasm components results inZhang et al. (1996) demonstrated that coexpression of
their nuclear translocation. However, our data showingelevated levels of DPC4 along with a novel MADR,
that in unstimulated cells MADR proteins are present intermed MAD-3, resulted in the synergistic activation of
the nucleus and the cytoplasm is more consistent withTGFb responses. Although these responses were ligand
a model inwhich the protein normallyexists inan equilib-independent, they suggest that DPC4 may function in
rium between these two compartments. Thus, phos-the TGFb signaling pathway. Since DPC4 does not asso-
phorylation may function to shift the equilibrium re-ciate with nor become phosphorylated by the TGFb re-
sulting in redistribution of the protein into the nucleus.ceptor, these data suggest that DPC4 may fulfill some
Within this context, phosphorylation may act to alter theother function that is not regulated by receptor-depen-
conformation of MADR2 or provide a docking site, thusdent phosphorylation of the molecule. It will be of inter-
allowing stable interaction with its nuclear targets andest to determine how the DPC4 class of MADR proteins
redistribution of the protein into the nucleus. Interest-are regulated by ser?thr kinase receptor signaling
ingly, recent studies of b-catenin have led to the pro-pathways.
posal of a similar model in which the nuclear accumula-
tion of b-catenin requires its specific interaction with a
DNA binding factor in the nucleus (Molenarr et al., 1996).Transient Association and Phosphorylation
of MADR2 Is Required for TGFb Signaling Given that the MH2 domain of MADR proteins are tran-
scriptional activators, it is intriguing to speculate thatWe have observed that phosphorylation of MADR2 is
necessary for its dissociation from the TGFb receptor. phosphorylation of MADR2 may drive association with
DNA binding proteins, thus leading to activation of tran-Blocking phosphorylation of MADR2 by mutation of the
sites for phosphorylation leads to stable association scription and initiation of TGFb responses.
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serum at 378C for 30 min, and the receptors were cross-linked toMADR Proteins Signal Directly from the Receptor
the ligand as described previously (Massague´, 1987). Cell lysatesto the Nucleus
were then subjected to immunoprecipitation as described above orIn signaling responses to extracellular factors, the nu-
total receptors visualized by separation on SDS-PAGE gels and
clear translocation or accumulation of signaling interme- autoradiography.
diates plays a central role in the transmission of signals
to the nucleus. In most systems, these events occur In Vitro Kinase Assay
several steps removed from the cell surface receptor, Receptor complexes immunoprecipitated from Mv1Lu, RIB, or tran-
siently transfected COS-1 cell lysates were washed three times withthus providing multiple opportunities for proteins from
lysis buffer followed by two washes in kinase buffer (5 mM Tris, [pHdiverse signaling systems to associate and create net-
7.4], 1 mM MgCl2, and 0.1 mM CaCl2). Receptor complexes wereworks of positively and negatively interacting signals.
incubated for 30 min at room temperature in kinase buffer containing
Our results show that MADR proteins are regulated di- 1 mM ATP, 20 mCi [g-32P]ATP, and bacterially expressed MADR2
rectly by the receptor kinase, resulting in accumulation or DPC4 protein as substrate. MADR proteins were expressed in
of MADR2 in the nucleus. This mechanism for MADR bacteria as a GST fusion proteinand purified as describedpreviously
(Smith and Corcoran, 1994). The eluted protein was dialyzed over-signaling would appear to restrict the possibility for in-
night at 48C in 10 mM Tris-HCl (pH 7.4), 0.1 mM EDTA, and 0.1teractions in the cytoplasm and may reduce the overlap
mM dithiothreitol, concentrated using Centricon 3 concentratorsbetween MADR signaling and other pathways. Indeed,
(Amicon) and 2 mg used as a substrate in the kinase assay. Protein
recent studies of the regulation of MADR1 and MADR2 phosphorylation was analyzed by SDS-PAGE and autoradiography.
phosphorylation have shown that they are regulated
specifically by BMP and TGFb signaling pathways, re- Transcriptional Response Assay
spectively (Eppert et al., 1996; Hoodless et al., 1996). For TGFb-inducible luciferase reporter assays, HepG2 cells were
transiently transfected with the reporter plasmid (p3TP-lux) and theOur studies clearly define an important role for phos-
indicated constructs or with empty vector alone. Cells were seededphorylated MADR2 in the nucleus. It will be interesting
at 25% confluency in 24-well plates and transfected overnight within the future to identify the nuclear targets of MADR2
0.5 mg DNA per well using the calcium phosphate–DNA precipitationand determine how these targets are regulated to initiate
method as described previously (Hoodless et al., 1996). To induce
TGFb signaling. the luciferase reporter, cells were treated overnight in 50 pM TGFb.
Luciferase activity was measured using the luciferase assay system
Experimental Procedures (Promega) in a Berthold Lumat LB 9501 luminometer.
Construction of Expression Vectors Immunofluorescence
The construction of Flag-MADR2 has been described previously HepG2 cells plated in gelatin-coated Permanox chamber slides
(Eppert et al., 1996). Mouse DPC4 was isolated from a 16 day mouse (Nunc) were transiently transfected with wild-type or mutant (3S-A)
embryo library (Novagen) using a DPC4 probe obtained from the Flag-MADR2 alone or with activated TbRI(T204D). Cells were fixed
expressed sequence tag database (Clone ID, 159476). For expres- in 4% paraformaldehyde, permeabilized, and MADR2 protein was
sion in mammalian cells, a full length clone was constructed in visualized using anti-Flag M2 and FITC-conjugated goat anti-mouse
pCMV5-Flag (Hoodless et al., 1996). For expression in bacteria, IgG as described previously (Hoodless et al., 1996). To visualize the
MADR2 or DPC4 was subcloned into pBluescript KS and then into fluorescence, a Zeiss Axioskop and a Leica microscope were used
pGEX4T1 using convenient restrictions sites. The mutants MADR2 for standard and confocal microscopy, respectively.
(R462A), MADR2(R462H), or MADR2(3S-A, where S464, 465, and
467 were changed into A), were generated by a polymerase chain
Acknowledgmentsreaction–based strategy (Attisano et al., 1996) and were fully se-
quenced.
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